Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Genome Editing Enhances CAR T-Cells to Fight Cancer

A process using genome editing is shown to bolster cancer-fighting properties of T-cells from the immune system already modified to attack cancer cells. . . . → Read More: Genome Editing Enhances CAR T-Cells to Fight Cancer

Process Devised for Continuous Stem Cell Production

Researchers in the U.K. developed a process for closed-loop continuous production and collection of large quantities of stem cells for therapies. . . . → Read More: Process Devised for Continuous Stem Cell Production

Thin, Flexible, Lower-Cost Motion Sensors Developed

Engineers in the U.S. and France created and tested motion-detecting sensors more flexible and thinner than today’s sensors, and made with a low-cost process. . . . → Read More: Thin, Flexible, Lower-Cost Motion Sensors Developed

Sanofi Acquires Multiple Sclerosis Drug in $800M Deal

Drug maker Sanofi is licensing a drug candidate from Principia Biopharma Inc. designed to treat multiple sclerosis, an autoimmune condition affecting the brain and nervous system. . . . → Read More: Sanofi Acquires Multiple Sclerosis Drug in $800M Deal

New Drug Shown to Reduce Depressive Behaviors

A new type of treatment for depression that works differently from most other anti-depressive drugs was shown in lab mice to reduce depression-like behaviors. . . . → Read More: New Drug Shown to Reduce Depressive Behaviors

Autonomous, Human-Friendly Forklifts Being Developed

An academic-industry team in Europe is developing new forklift vehicles that can work safely alongside humans in warehouses. . . . → Read More: Autonomous, Human-Friendly Forklifts Being Developed

RNA Meds Companies Partner on Human, Animal Vaccines

Synthetic Genomics Inc. and Arcturus Therapeutics Inc. are collaborating on longer-lasting and more robust RNA therapies and vaccines for humans and animals. . . . → Read More: RNA Meds Companies Partner on Human, Animal Vaccines

Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Drug maker Novartis is purchasing a company that develops therapies and diagnostics using radio isotopes for neuroendocrine and other cancers. . . . → Read More: Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Blood-Thinning Drugs Linked with Lower Dementia Risk

People with irregular heart rhythms given anti-coagulation drugs to reduce their risk of stroke were also less likely to develop dementia than their counterparts not receiving blood-thinners. . . . → Read More: Blood-Thinning Drugs Linked with Lower Dementia Risk

Big Data Analysis Platform for Brainwaves in Development

Two companies in Northern Ireland, U.K. are creating a technology platform applying big data analytics to a collection of brainwaves generated by mobile games for measuring cognitive health. . . . → Read More: Big Data Analysis Platform for Brainwaves in Development